International Patent: INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF

GENEVA, Sept. 7 -- MAZE THERAPEUTICS, INC. filed a patent application (US2026/016493) for “INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF”. With publication no. WO/2026/183125, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 333/58

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....